Background: Volatile anesthetics exert their negative chronotropic and inotropic effects, in part by depressing the L-and T-type calcium channels. This study examines and compares the dose-dependent effects of isoflurane on atrial L-and T-type calcium currents (I Ca,L and I Ca,T ) and ventricular I Ca,L .
VOLATILE anesthetics have negative inotropic and chronotropic effects on cardiac function. 1 In vivo and in vitro studies have shown that these anesthetics depress automaticity of the sinoatrial node and conduction velocity in the atrioventricular node. In so far as the action potentials of these cardiac tissues depend on calcium influx through calcium channels, one of the inhibitory effects of these anesthetics may be by blocking the Land T-type calcium channels. 2 Volatile anesthetics are known to depress cardiac contractility, in part by inhibiting L-(I Ca,L ) and T-type calcium channel currents (I Ca,T ), necessary for excitation-contraction coupling. 3, 4 In the adult cardiac muscle, the two types of calcium channels play different functional roles. I Ca,L underlies the "slow inward" current of the action potential in atrial and ventricular myocytes, and I Ca,T underlies the transient current that may regulate action potential in pacemaker cells and atrial cells. I Ca,T have been reported also in ventricular cells, but its current magnitude is significantly smaller than the ventricular L-type. 5 Because the main physiologic function of ventricular cells is contraction, L-type calcium channels play a major role in providing external Ca 2ϩ required for excitation-contraction coupling. In the depolarized region of the atrioventricular node, L-type calcium channel currents are also important in the generation of and plateau phase of the slow action potential. Unlike the L-type calcium channel, the role of the cardiac T-type calcium channel contributes little to the Ca 2ϩ influx responsible for muscle contraction. However, other studies have reported that activation of ventricular T-type calcium channels could lead to Ca 2ϩ release from the sarcoplasmic reticulum. 5 The Ttype calcium channel, because of its voltages of activation and inactivation, may be involved in the late phase of diastolic depolarization in pacemaker cells. 6 The two channels can also be separated by their voltage-dependent activation and inactivation; I Ca,L requires a strong depolarization for activation and decays slowly during maintained depolarization. The T-type calcium current, on the other hand, is activated at more negative potentials than the L-type and is rapidly inactivated during sustained depolarization. 6 In addition, the two calcium channels can be distinguished pharmacologically; pharmacologic agents such as dihydropyridines, phenylalkylamines, and benzothiazepines inhibit I Ca,L , while nickel and mibefradil preferentially block I Ca,T . [7] [8] [9] Although volatile anesthetics depress calcium currents, differences in the sensitivities of the L-and T-type calcium channels to the anesthetics have been reported. McDowell et al. 10 showed that low-voltage activated calcium channels of the thyroid C-cell line were more sensitive to isoflurane and enflurane than high-voltage activated calcium channels. In a recent study, McDowell et al. 11 also demonstrated differential effects of volatile anesthetics on T-type calcium channels from different types of tissue. However, previous studies from this laboratory have shown that volatile anesthetics inhibit Purkinje fiber L-and T-type calcium channels equally. 12 Therefore, to further characterize how volatile anesthetics alter cardiac function, we investigated the effects of isoflurane on atrial L-and T-type calcium channels and compared anesthetic effects on the L-type calcium channels of atrial and ventricular myocytes. The results show that isoflurane reversibly suppressed atrial I Ca,T more than atrial I Ca,L , and the ventricular I Ca,L was the least sensitive to the anesthetic. The magnitude of the depressions of atrial and ventricular I Ca,L induced by isoflurane was also associated with a reversible hyperpolarizing shift in the reversal potential for calcium.
Materials and Methods

Atrial and Ventricular Cell Isolation
The isolation procedure for cardiac myocytes from guinea pigs was approved by the Medical College of Wisconsin Animal Care and Use Committee. Single atrial and ventricular myocytes were isolated from the hearts of adult guinea pigs (SASCO, Wilmington, MA) weighing 180 -250 g. The procedure of the cell isolation is a modification of that of Mitra and Morad 13 and has been described previously.
14 Briefly, the guinea pigs were injected intraperitoneally with 10,000 USP units of heparin and anesthetized with pentobarbital sodium (250 mg/kg intraperitoneally). Hearts were rapidly extracted after thoracotomy and mounted on a Langendorff apparatus for perfusion via the ascending aorta. The hearts were perfused at a rate of 7 ml/min at 37°C with Joklik medium (Gibco minimum essential medium) containing heparin at pH 7.23 (95% O 2 -5% CO 2 oxygenation). After 3-4 min, the Joklik solution was removed, and the hearts were perfused with recirculating enzyme solutions containing a heparin-free Joklik medium with 0.6 mg/ml collagenase (GIBCO type II; Life Technologies, Grand Island, NY), 0.1 mg/ml protease Type XIV (Sigma Chemical Co., St. Louis MO), and 1 mg/ml bovine serum albumin solution (Pentex, Bayer Corp., Kankakee IL), pH 7.23 (95% O 2 -5% CO 2 , oxygenation).
Isolation of Atrial Cells
Atrial cells were obtained during the initial stage of the cell isolation procedure. After 3-4 min of perfusion with enzymes on the Langendorff apparatus, the auricles were cut and minced in 10 ml of Tyrode solution at 37°C. The minced auricles were then transferred into a small flask, placed in a water bath (37°C), and shaken for 3 min. After shaking, the dispersed tissue and cells were filtered through a 210-m spectral mesh in a test tube and left to settle before experimentation.
Isolation of Ventricular Cells
From the same heart after the auricles were cut, the ventricles were removed after 14 min of enzyme digestion and minced in the enzyme solution. They were then transferred into small flasks containing enzyme solution and incubated for an additional 3-8 min in a shaker water bath (37°C) to disperse the cells. The dispersed cells were then filtered and centrifuged. The resulting pellet was first washed in the recovery solution (Joklik medium supplemented with 0.1 mM CaCl 2 and 1 mg/1 ml bovine albumin fraction V; Pentex) and then with Tyrode solution. The isolated ventricular myocytes were stored in Tyrode solution at room temperature for studies. Isoflurane (Ohmeda Caribe Inc., Liberty Corner, NJ) was delivered in the superfusate after a vigorous mixture of an aliquot of the anesthetic with a fixed volume of external Ca 2ϩ solution. To determine the effect of isoflurane on I Ca , the inflow perfusate was changed to one in which a given concentration of the anesthetic agent had been equilibrated. At the end of each experiment, solution samples of the chamber were taken and analyzed by gas chromatography (GC-8AIF, Shimadzu Corp., Kyoto, Japan) to verify the anesthetic concentration surrounding the cell.
Solutions and Reagents
Whole Cell Patch Configuration
A drop of cell suspension (atrial or ventricular myocytes) was placed on a Plexiglas chamber mounted on the stage of an inverted microscope (Olympus IMT2, Tokyo, Japan) and superfused with Tyrode solution. Experiments involving atrial cells were conducted within 6 h after isolation, and the selected cells were spindle shaped and showed distinct borders and striations. For ventricular myocytes, the cells were used within 10 h after isolation, and rod shaped cells with clear borders and striations were selected. Pipettes from borosilicate glass were pulled with a multistage puller (Sachs-Flaming, PC-84; Sutter Instrument Company, Novato, CA) and heat polished (Narishige microforge, MF-83; Setagaya-KU, Tokyo, Japan). The polished pipettes had tip resistances of 2.5-4.5 m⍀. High-giga-ohm seals and whole cell voltage clamp were attained in Tyrode solution, followed by superfusion of the chamber with the external Ca 2ϩ solution. Whole cell calcium currents using the patch clamp technique were recorded at room temperature. Currents were recorded using a List EPC-7 patch clamp amplifier (Adams and List Assoc., Great Neck, NY), and the output was filtered at 3 kHz to reduce high frequency noise. Data acquisition and analysis were performed using the pCLAMP software package (Version 6.0; Axon Instruments, Inc., Foster City, CA). Additional analysis was performed using ORIGIN version 4.0 software (Microcal Software Inc., Northampton, MA).
In ventricular and atrial myocytes, I Ca,L was elicited during 50-ms depolarizing test pulses (200 ms duration) to ϩ60 mV (10-mV increments) from a holding potential of Ϫ50 mV. To elicit I Ca,T in atrial cells, depolarizing test pulses were initiated from holding potentials of Ϫ90 and Ϫ50 mV. I Ca,T was obtained by digital subtraction of currents obtained at holding potential of Ϫ50 mV (where the L-type is elicited) from currents elicited from a holding potential of Ϫ90 mV (where both L-and T-type are elicited) in the same cell.
Data Analysis
After obtaining whole cell configuration, calcium current was initially recorded for 15 min to monitor timedependent changes in peak calcium current amplitude. Cells that showed a significant change in current amplitude because of rundown (i.e., Ͼ 5%) during the stabilization period of 15-20 min, or did not show at least 80% recovery during washout, were not included in analysis of the data. Current-voltage (I-V) relations were obtained during control (anesthetic-free external Ca 2ϩ solution), in the presence of anesthetic, and during washout (recovery) for each cell. The effects of anesthetic on peak I Ca are reported as percentage block of the current amplitude in the presence of isoflurane compared with control. Concentration-response curves for block of the peak I Ca by isoflurane were obtained by nonlinear regression to a sigmoidal equation:
where B is a block by anesthetic, M is the maximum block by the anesthetic, [A] is concentration of the anesthetic, K d is the anesthetic concentration for half maximal effect, and n H is the Hill coefficient. Steady-state activation was obtained by calculating conductance from:
where I Ca is the current amplitude, V is the test potential, and E rev is the reversal potential for calcium, which was approximately 50 -60 mV during control conditions. The conductance was normalized to maximum conductance, g max . To monitor steady-state inactivation of atrial and ventricular I Ca,L , cells were subjected to 1-s preconditioning test pulses ranging from Ϫ50 mV (holding potential) to ϩ40 mV (in 10-mV increments) before stepping to the test pulse of ϩ20 or ϩ30 mV, the potential at which peak I Ca,L current occurred. Steady state T-type current inactivation was determined by imposing 1-s preconditioning voltage pulses ranging from Ϫ90 (holding potential) to Ϫ30 mV before stepping to the test pulse of Ϫ30 mV, the potential at which peak I Ca,T occurs. At Ϫ30 mV test pulse, I Ca,L was not activated. Peak currents obtained at the test potential were normalized to the maximum current (I max ). Both steadystate activation and inactivation were fitted to a Boltzmann equation of the form:
where V is the membrane potential (for activation) or preconditioning potential (for inactivation), V 1/2 is the voltage where activation or inactivation is half maximal, and k is the slope factor.
Statistical Analysis
Data are presented as mean Ϯ SEM. Dose-related inhibition of I Ca was analyzed using one-way analysis of variance. Multiple-comparison analysis of variance with repeated measures was used to analyze the betweengroup differences. The Student-Newman-Keuls procedure (least significant range) was used a posteriori to determine differences between mean values. All statistical analyses were conducted using commercially available software from SigmaStat (Jandel Scientific, Corte Madera, CA). A test result was considered significant when P Յ 0.05. . Current traces in figures 1A and B show I Ca,L elicited by depolarizing test pulses to Ϫ30 mV and ϩ10 mV from holding potentials of Ϫ50 and Ϫ90 mV, respectively. With the cell held at Ϫ50 mV, I Ca,L was present during a test step to ϩ10 mV but not at Ϫ30 mV. From a holding potential of Ϫ90 mV, both I Ca,T and I Ca,L were elicited by depolarizing step pulses to Ϫ30 and at ϩ10 mV, respectively. Subsequent subtraction of traces recorded from a holding potential of Ϫ50 mV from those obtained at Ϫ90 mV yielded the T-type calcium current ( fig. 1C ) in atrial myocytes. During our recording conditions, ventricular T-type calcium channel currents were not studied because they were not observed. Figure 2 depicts representative whole cell ventricular L-and atrial L-and T-type calcium current traces and their corresponding I-V relations recorded in the absence (control) and presence of isoflurane. The average peak current amplitude during control conditions (2 mM external Ca 2ϩ ) for atrial T-and L-type and ventricular L-type calcium currents were 101 Ϯ 4 (n ‫؍‬ 51), 211 Ϯ 6 (n ‫؍‬ 56), and 511 Ϯ 13 pA (n ‫؍‬ 61), respectively. In the examples shown in figure 2, isoflurane at 0.9 mM depressed peak I Ca in both L-(atrial and ventricular) and T-type (atrial) calcium channels. The corresponding I-V values show that the depression of I Ca by isoflurane was reversed after washout of the anesthetic.
Results
To compare the relative sensitivity of atrial L-and T-type calcium channels and ventricular L-type calcium channels to isoflurane, concentration-response curves were determined. Isoflurane block was calculated as a percent reduction in the peak current amplitude measured during depolarizing test pulses in the presence of various concentrations of the anesthetic compared with control. The respective K d values for atrial T-and L-type and ventricular L-type calcium channels were 0.23 Ϯ 0.03, 0.34 Ϯ 0.03, and 0.71 Ϯ 0.06 mM (fig. 3 ). These significant differences in K d values show that the atrial T-type calcium channel is most sensitive and the ventricular L-type calcium channel is the least sensitive to the blocking action of isoflurane. The Hill coefficients were 1.5 Ϯ 0.3 and 1.7 Ϯ 0.2 for atrial T-and L-type calcium channels, respectively, and 2.8 Ϯ 0.5 for the ventricular L-type calcium channel. The differences were not statistically significant. Figure 4 demonstrates the effects of isoflurane on steady-state inactivation in atrial T-and L-type and ventricular L-type calcium channels. In the example shown, isoflurane produced a shift in the hyperpolarizing direction for all three cases. During control conditions, the average V 1/2 and k values for atrial T-type calcium channel current were Ϫ57.4 Ϯ 0.6 and 6.9 Ϯ 0.3 mV, respectively. The average values for V 1/2 and k for atrial and ventricular L-type calcium channel currents during control conditions were Ϫ15.1 Ϯ 0.6 and 5.3 Ϯ 0.3 mV and Ϫ14.9 Ϯ 0.1 and 5.2 Ϯ 0.1 mV, respectively. After the administration of isoflurane, there was a dose-dependent hyperpolarizing shift in V 1/2 for both atrial and ventricular calcium channels. Table 1 summarizes the dosedependent shifts in V 1/2 of steady-state inactivation by isoflurane. At 0.25 mM isoflurane, a small but significant shift in V 1/2 occurred in atrial T-type channel but not in the atrial and ventricular L-type channels. At 0.9 mM isoflurane, the shift in steady state inactivation was significantly greater (P Ͻ 0.05) in the atrial L-type than the atrial T-and ventricular L-type calcium channels. However, at 1.20 mM isoflurane, the shift in steady state inactivation was significantly (P Ͻ 0.05) greater in both atrial and ventricular L-type calcium channels than the atrial T-type calcium channels. The k values did not change significantly in the presence of isoflurane.
The effects of isoflurane on steady-state activation for atrial L-and T-type and ventricular L-type calcium channel currents were less pronounced than those observed for steady-state inactivation ( fig. 5 ). During control conditions, the average V 1/2 for steady-state activation for atrial T-and L-type and ventricular L-type calcium channels were Ϫ30.6 Ϯ 0. respectively, and 8.3 Ϯ 0.2 mV for the ventricular L-type calcium channel. Table 2 summarizes the effects of isoflurane on steady-state activation in atrial and ventricular L-and T-type calcium channels. For the ventricular L-type calcium channel, only at higher isoflurane concentrations of 1.2 and 1.6 mM was a depolarizing shift in V 1/2 significant. Isoflurane did not significantly affect the steady state activation of the atrial L-and T-type calcium currents. The slope factor, k, did not change significantly in all cases after the addition of isoflurane.
In addition to the inhibitory effect on I Ca , isoflurane also caused a significant hyperpolarizing shift in the apparent reversal potential (E rev ) for the atrial and ventricular L-but not for the T-type calcium channels ( fig.  2 ). E rev was determined graphically from the I-V relation. During control conditions (2 mM extracellular Ca 2ϩ ), the average E rev for the atrial and ventricular L-type calcium channels were 59.7 Ϯ 2.3 and 59.1 Ϯ 0.7 mV, respectively. Isoflurane induced dose-dependent negative changes in E rev in atrial and ventricular L-type calcium channel currents (figure 6A). These hyperpolarizing shifts in E rev were reversed toward control values after washout of the anesthetic. To test whether these hyperpolarizing shifts in E rev were dependent on extracellular Ca 2ϩ , experiments were conducted using ventricular myocytes to determine the effects of 0.9 mM isoflurane on E rev in the presence of increased extracellular Ca 2ϩ concentration ( fig. 6B ). At higher concentrations of extracellular Ca 2ϩ , the shifts in E rev induced by isoflurane were diminished.
Discussion
This study compared the effects of isoflurane on atrial L-and T-type and ventricular L-type calcium channel currents from the guinea pig heart. At clinically relevant concentrations, isoflurane differentially depressed atrial and ventricular calcium channel currents. Atrial T-type calcium channels showed the greatest sensitivity to isoflurane, followed by atrial L-type and the ventricular L-type calcium channels. This dose-dependent block of I Ca by isoflurane within the clinical range shows saturation at higher concentrations for atrial L-and T-type but not for the ventricular L-type calcium channel. Isoflurane also induced dose-dependent hyperpolarizing shifts in V 1/2 of steady-state inactivation in atrial L-and T-type and ventricular L-type calcium channel currents. At higher concentrations, isoflurane induced a significant depolarizing shift in steady-state activation in ventricular L-type but not in atrial L-or T-type calcium channel current. Isoflurane also induced a hyperpolarizing shift in E rev for the atrial and ventricular L-type calcium channel currents, and this effect was diminished in the presence of elevated extracellular Ca 2ϩ concentrations.
Studies by other investigators reported similar hyperpolarizing shifts in steady-state inactivation by volatile anesthetics in ventricular I Ca,L . 3, 15 The hyperpolarizing shift in V 1/2 of the inactivation curve suggests that isoflurane depresses I Ca in guinea pig atrial and ventricular myocytes, in part by reducing the availability of calcium channels necessary for the influx of Ca 2ϩ ions on depolarization. Furthermore, in ventricular cells, the depolarizing shift in activation curve at 1.2 and 1.6 mM isoflurane indicates that, at higher concentrations (above clinical levels), the depression of peak I Ca,L may also involve a decrease in ion conductance. The change in steady-state activation may be caused by isoflurane-induced alteration in the rate constants from closed to open states. The magnitude of shifts in steady-state inactivation curve was less in the atrial T-type than the L-type calcium channels (table 1), although the depression of peak I Ca was greater in the T-type channel ( fig. 3) . These differences in shifts in inactivation curves between the atrial and ventricular L-and T-type calcium channels suggest that the depression of I Ca,T in atrial cells may depend less on the effects of isoflurane on calcium channel availability when compared with the L-type calcium channel. Furthermore, the shift in steady-state activation in the ventricular but not in the atrial L-type calcium channels by high concentrations of isoflurane suggest that the L-type calcium channels in the two chambers may be modulated differently by volatile anesthetics. No significant changes in k by isoflurane were observed, indicating that the channels voltage sensor was not affected.
The pharmacologic results of this study may suggest heterogeneity in the L-and T-type calcium channels in the guinea pig heart. Studies by other investigators have compared the effects of volatile anesthetics on calcium channels between and also within cell types. For example, McDowell et al. 10 showed that, in a thyroid C-cell line, isoflurane and enflurane blocked T-type calcium channels more potently than either L-or N-type calcium channels. In a recent preliminary study, Yamakage et al. 16 reported that, in porcine bronchial smooth muscle cells, the T-type calcium channel was more responsive than the L-type calcium channel to inhibition by volatile anesthetics. However, anesthetic depression of the bronchial L-type calcium channel was similar to its depression of the tracheal L-type calcium channel. In smooth muscle cells obtained from guinea pig portal vein, the T-type calcium channel was less sensitive than the L-type calcium channel to isoflurane. 17 Previous studies from this laboratory showed that, in the canine Purkinje fiber, the L-and T-type calcium channels showed similar sensitivities to isoflurane, enflurane, and halothane. 12 However, in the current study using guinea pig hearts, the atrial T-type calcium channels were more sensitive to isoflurane than the atrial and ventricular L-type calcium channels. In addition, the atrial L-type calcium channels were more responsive to isoflurane than the ventricular L-type calcium channel. The discrepancies in these studies may be attributed to tissue and functional differences between atrial and Purkinje fibers. In the canine heart, the ventricular L-type calcium channel current has been shown to have properties that are different from the conducting Purkinje fiber L-type calcium channel. For example, the decay of I Ca,L is slower in ventricular cells than in Purkinje cells. 18 The differences in responses may also be ascribed to species differences. Heterogeneity in the L-and T-type calcium channel functions have been attributed to the expression of distinct pore forming ␣ 1 subunits, the selective association with accessory subunits and other modulatory proteins associated with the channels. 19 The underlying molecular structure of the L-type calcium ␣ 1C subunit present in heart, smooth muscle, and neurons 20 -22 is different from the recently cloned human heart ␣ 1H subunit of the T-type calcium channel. [23] [24] [25] [26] The ␣ 1C subunit is also modulated by accessory subunits that may be different from the accessory subunits associated with the ␣ 1H subunit of the T-type calcium channel. 19, 24, 25, 27, 28 The Land T-type calcium channels are also modulated differentially by neuromediators and intracellular mechanisms involving protein kinases and phosphorylation-dependent pathway. 8, 18 Takenoshita and Steinbach 29 reported that, in rat DRG cells, the greater sensitivity of the lowvoltage (T-type) calcium channel to halothane when compared with the high-voltage (L-type) calcium channel might be attributed to the differences in signal transduction pathways that modulate the two channels. 29 These differences in ␣ 1 isoforms and differences in intracellular modulators could contribute to the differences in responses of the L-and T-type calcium channels to isoflurane.
The differences in sensitivities to isoflurane by the atrial and ventricular L-type calcium channels may also suggest the existence of variants of the cardiac L-type calcium ␣ 1C subunit. Splice variants of the human fibroblast ␣ 1C subunit for the L-type calcium channel have been shown to respond differently to the inhibitory action of isradipine. 30 In the cardiovascular system, variants of the ␣ 1C subunit are responsible for greater sensitivity of smooth muscle L-type calcium channel to nitrendipine when compared with cardiac L-type calcium channel. 20 These differential responses may be attributed to specific segments of the transmembrane protein and splice variants of the accessory subunits that modulate the ␣ 1 subunit. 19, 21, 30 If similar variations in isoforms of the L-type exist in the heart, this may explain why the atrial L-and ventricular L-type calcium channels showed different sensitivities to isoflurane. However, whether isoforms of the L-type calcium channel ␣ 1C subunit and variations in their accessory subunits exist for atrial and ventricular myocytes of the two chambers remains to be tested. Another plausible explanation for the differences in the sensitivity of the atrial and ventricular L-type calcium channels could be diversity in the regulation of the L-type calcium channels in the two chambers. Thus, in the presence of isoflurane, the modulation of the L-type calcium channels in the atria and ventricle could involve other modulatory proteins in the local environment around the channel or in subsequent steps in signal transduction pathways. In support of this notion, we have recently shown that isoflurane might depress atrial and ventricular L-type calcium channel currents by different regulatory pathways. Preliminary results show that, at clinically relevant concentrations, isoflurane might inhibit ventricular but not atrial I Ca,L via a cholinergic-dependent signal transduction cascade. 31, 32 Thus, atrial and ventricular cells may contain receptors or intracellular mediators that may contribute to differential anesthetic sensitivity.
An interesting observation of this study is the reversible dose-dependent hyperpolarizing shift in the apparent E rev of the atrial and ventricular I Ca,L induced by isoflurane. This negative shift in reversal potential by isoflurane was attenuated by increases in extracellular Ca 2ϩ concentration ( fig. 6 ). This reduction in the shift in E rev by isoflurane in the presence of elevated external Ca 2ϩ suggests that the shift may partly be attributed to selectivity changes of the calcium channel by the anesthetic, although further experiments are needed to confirm this. The notion that the calcium channel may be permeable to other monovalent ions has been suggested. 33, 34 Study 35 reported a similar hyperpolarizing shift in the calcium E rev in the presence of isoflurane in hippocampal pyramidal neurons. According to Study, the shift in the reversal potential may be attributed to an increase in outward rectification caused, in part, by movement of Cl Ϫ , 36 which is reversed in the presence of Cd 2ϩ . 35 Studies by Mitra and Morad 37 have also shown that Cs ϩ ion fluxes through the inward rectifier potassium channel may contribute to shift in the reversal potential. In the current study, however, it is unlikely that Cs ϩ flux through the inward rectifier potassium channel contributed to the shift in the reversal potential. At the two holding potentials used in this study, Ϫ50 and Ϫ90 mV, the holding current amplitude was zero in control and in the presence of isoflurane. Furthermore, the concentrations of extracellular Cs ϩ , 30 -120 mM, was significantly higher in the study by Mitra and Morad. 37 Consequently, the contribution of the inward rectifier potassium channel to changes in the observed reversal potential is likely negligible.
In summary, the current study shows that the calcium channels in the atria and ventricles respond differently to isoflurane. The differences in sensitivity and actions of the anesthetic on the channels may represent phenotypic differences in the calcium channels or differences in the regulation of the channels. Nonetheless, the differential sensitivities of the channels to isoflurane, particularly at the lower concentrations, could cause a disparity in the refractory periods in the two chambers, which could cause conduction abnormalities during anesthesia.
